Dr. Steven Mark Bloom, MD

Dr. Bloom practices at Bennett & Bloom Eye Centers in Louisville, Kentucky.

Dr. Bloom's NPI, 1346224409, was assigned on December 2, 2005. Dr. Bloom graduated from MCP-Hahnemann College of Medicine in 1984. Dr. Bloom holds Kentucky license 26932.

Dr. Bloom's primary practice is Bennett & Bloom Eye Centers, at 9200 Leesgate Rd, Louisville, KY 40222 in Jefferson County. The practice phone is (502) 895-0040.

Dr. Bloom's primary practice is Bennett & Bloom Eye Centers in Louisville, Kentucky. Dmand AI also links Dr. Bloom to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bloom practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Bloom's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Bloom is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Bloom's licenses on file in 6 states: Kentucky, Florida, Maine, Indiana, Tennessee and Pennsylvania.

Dmand AI lists age-related macular degeneration, cataract, dry eye, glaucoma, hereditary corneal conditions, inflammation of iris, laser destruction of retinal or choroid lesions and retinal detachment among the conditions Dr. Bloom treats.

CMS data shows 46,290 Medicare services from Dr. Bloom across 19 procedure codes in 2024, for 1,203 Medicare patients. Medicare paid $2,550,828 for them. Every service was in an office.

CMS counts 1,203 Medicare patients who saw Dr. Bloom in 2026. The largest group is 65 to 74, with 460 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bloom's median patient age at 70, with 57% women.

In 2026, Dr. Bloom wrote 565 Medicare Part D claims for 171 patients. 61% of them were for generic drugs. CMS names the drug for 433 of them, across 12 drugs with 11 or more claims each, at $25,031 in total drug cost. In 2023, CMS named 495 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Bloom for performance year 2026, reported as part of a group. Dr. Bloom accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 53 papers to Dr. Bloom, published from 2011 to 2025. 2023 was the busiest year, with 11. The most frequent topics are Fluorescein Angiography, Tomography, Optical Coherence and Vitrectomy. Dr. Bloom has published most often in Ophthalmic Surg Lasers Imaging Retina. Dr. Bloom's most frequent co-authors are Kourous A. Rezaei, MD, Inder Pal Singal, MD and Miguel A. Busquets, MD.

CMS Open Payments shows 188 general payments to Dr. Bloom from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 56% of the total. Merck Sharp & Dohme Corporation paid the most, $3,115.

Dmand AI lists 2 awards for Dr. Bloom.

Dr. Bloom graduated from MCP-Hahnemann College of Medicine in 1984. Dr. Bloom is a member of ACS.

Dr. Bloom is in network with 18 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.